Literature DB >> 24831595

Brain parenchymal signal abnormalities associated with developmental venous anomalies in children and young adults.

L L Linscott1, J L Leach2, B Zhang3, B V Jones2.   

Abstract

BACKGROUND AND
PURPOSE: Abnormal signal in the drainage territory of developmental venous anomalies has been well described in adults but has been incompletely investigated in children. This study was performed to evaluate the prevalence of brain parenchymal abnormalities subjacent to developmental venous anomalies in children and young adults, correlating with subject age and developmental venous anomaly morphology and location.
MATERIALS AND METHODS: Two hundred eighty-five patients with developmental venous anomalies identified on brain MR imaging with contrast, performed from November 2008 through November 2012, composed the study group. Data were collected for the following explanatory variables: subject demographics, developmental venous anomaly location, morphology, and associated parenchymal abnormalities. Associations between these variables and the presence of parenchymal signal abnormalities (response variable) were then determined.
RESULTS: Of the 285 subjects identified, 172 met inclusion criteria, and among these subjects, 193 developmental venous anomalies were identified. Twenty-six (13.5%) of the 193 developmental venous anomalies had associated signal-intensity abnormalities in their drainage territory. After excluding developmental venous anomalies with coexisting cavernous malformations, we obtained an adjusted prevalence of 21/181 (11.6%) for associated signal-intensity abnormalities in developmental venous anomalies. Signal-intensity abnormalities were independently associated with younger subject age, cavernous malformations, parenchymal atrophy, and deep venous drainage of developmental venous anomalies.
CONCLUSIONS: Signal-intensity abnormalities detectable by standard clinical MR images were identified in 11.6% of consecutively identified developmental venous anomalies. Signal abnormalities are more common in developmental venous anomalies with deep venous drainage, associated cavernous malformation and parenchymal atrophy, and younger subject age. The pathophysiology of these signal-intensity abnormalities remains unclear but may represent effects of delayed myelination and/or alterations in venous flow within the developmental venous anomaly drainage territory.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2014        PMID: 24831595      PMCID: PMC7964448          DOI: 10.3174/ajnr.A3960

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  De novo formation of a cavernous malformation of the brain in the presence of a developmental venous anomaly.

Authors:  S Cakirer
Journal:  Clin Radiol       Date:  2003-03       Impact factor: 2.350

2.  Thrombosis of developmental venous anomalies of the brain after liver transplantation.

Authors:  Roberto Ballarin; Fabrizio Di Benedetto; Nicola De Ruvo; Michele Masetti; Roberto Montalti; Mario Spaggiari; Cristina Longo; Giorgio Enrico Gerunda
Journal:  Transplantation       Date:  2009-02-27       Impact factor: 4.939

3.  Development of a cavernous malformation of the brain.

Authors:  P Maeder; F Gudinchet; R Meuli; N de Tribolet
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

4.  Developmental venous anomalies--two cases with venous thrombosis.

Authors:  Mario Teo; Jerome St George; Sarah Jenkins; Patricia Littlechild
Journal:  Br J Neurosurg       Date:  2012-05-28       Impact factor: 1.596

5.  Coexistence of occult vascular malformations and developmental venous anomalies in the central nervous system: MR evaluation.

Authors:  T Abe; R J Singer; M P Marks; A M Norbash; R S Crowley; G K Steinberg
Journal:  AJNR Am J Neuroradiol       Date:  1998-01       Impact factor: 3.825

6.  Mixed vascular malformations of the brain: clinical and pathogenetic considerations.

Authors:  I A Awad; J R Robinson; S Mohanty; M L Estes
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

7.  Parenchymal hypointense foci associated with developmental venous anomalies: evaluation by phase-sensitive MR Imaging at 3T.

Authors:  M Takasugi; S Fujii; Y Shinohara; T Kaminou; T Watanabe; T Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-18       Impact factor: 3.825

8.  Hemodynamic effects of developmental venous anomalies with and without cavernous malformations.

Authors:  A Sharma; G J Zipfel; C Hildebolt; C P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-18       Impact factor: 3.825

9.  Parenchymal abnormalities associated with developmental venous anomalies.

Authors:  Diego San Millán Ruíz; Jacqueline Delavelle; Hasan Yilmaz; Philippe Gailloud; Enrico Piovan; Alberto Bertramello; Francesca Pizzini; Daniel A Rüfenacht
Journal:  Neuroradiology       Date:  2007-08-17       Impact factor: 2.804

Review 10.  Thrombosis of a drainage vein in developmental venous anomaly (DVA) leading venous infarction: a case report and review of the literature.

Authors:  Yilmaz Kiroglu; Ismail Oran; Tayfun Dalbasti; Nevzat Karabulut; Cem Calli
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

View more
  14 in total

Review 1.  Developmental venous anomalies of the brain in children -- imaging spectrum and update.

Authors:  Luke L Linscott; James L Leach; Blaise V Jones; Todd A Abruzzo
Journal:  Pediatr Radiol       Date:  2016-01-21

Review 2.  Bilateral thalamic developmental venous variations (DVVs) draining into same internal cerebral vein: a case report and review with emphasis on DVVs with outflow restriction.

Authors:  Hilal Sahin; Yeliz Pekcevik
Journal:  Surg Radiol Anat       Date:  2016-01-12       Impact factor: 1.246

3.  Developmental Venous Anomalies Mimicking Neoplasm on 11C-Methionine PET and DSC Perfusion MRI.

Authors:  Julie H Harreld; Mikhail Doubrovin; Elizabeth R Butch; Angela Edwards; Barry Shulkin
Journal:  Clin Nucl Med       Date:  2017-05       Impact factor: 7.794

4.  Sensitivity of susceptibility-weighted imaging in detecting developmental venous anomalies and associated cavernomas and microhemorrhages in children.

Authors:  Allen Young; Andrea Poretti; Thangamadhan Bosemani; Reema Goel; Thierry A G M Huisman
Journal:  Neuroradiology       Date:  2017-06-30       Impact factor: 2.804

Review 5.  Venous pathologies in paediatric neuroradiology: from foetal to adolescent life.

Authors:  Kshitij Mankad; Asthik Biswas; Maria Camilla Rossi Espagnet; Luke Dixon; Nihaal Reddy; Ai Peng Tan; Ozgur Oztekin; Felice D'Arco; Karuna Shekdar; Prakash Muthusami; Fergus Robertson; Stacy Goergen; Winston Chong
Journal:  Neuroradiology       Date:  2019-11-09       Impact factor: 2.804

6.  Epilepsy Lesion Localization is not Predicted by Developmental Venous Anomaly Location or its FDG-PET Metabolic Activity.

Authors:  Jillian W Lazor; Joel M Stein; James Eric Schmitt; Kathryn A Davis; Seyed Ali Nabavizadeh
Journal:  J Neuroimaging       Date:  2020-05-08       Impact factor: 2.486

7.  Prevalence and anatomical characteristics of developmental venous anomalies: an MRI study.

Authors:  Karolina Brzegowy; Natalia Kowalska; Bernard Solewski; Agata Musiał; Tomasz Kasprzycki; Izabela Herman-Sucharska; Jerzy A Walocha
Journal:  Neuroradiology       Date:  2020-11-23       Impact factor: 2.804

8.  Increased Prevalence of Developmental Venous Anomalies in Children with Intracranial Neoplasms.

Authors:  B V Jones; L Linscott; G Koberlein; T R Hummel; J L Leach
Journal:  AJNR Am J Neuroradiol       Date:  2015-05-28       Impact factor: 3.825

9.  Brain metabolic abnormalities associated with developmental venous anomalies.

Authors:  M Larvie; D Timerman; J A Thum
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-04       Impact factor: 3.825

10.  The Central Vein: FLAIR Signal Abnormalities Associated with Developmental Venous Anomalies in Patients with Multiple Sclerosis.

Authors:  D M Rogers; L M Shah; R H Wiggins
Journal:  AJNR Am J Neuroradiol       Date:  2018-10-18       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.